Copernican Piccoleto VIII
COPERNICAN PICCOLETO VIII is a prospective, pragmatic, multicenter, non-inferiority, randomised clinical trial that compares the effectiveness of a reduced stent strategy using drug-coated balloons …
COPERNICAN PICCOLETO VIII is a prospective, pragmatic, multicenter, non-inferiority, randomised clinical trial that is designed to compare the effectiveness of a reduced stent strategy using drug-coated balloons (DCB) for percutaneous coronary intervention (PCI) with the standard drug-eluting stent (DES) treatment in patients with ST-segment myocardial infarction (STEMI). The aim of the study is to show that the reduced stent strategy is not inferior to the conventional DES-based revascularisation in treating STEMI patients. This study has the potential to significantly impact and improve the current treatment options for patients with this type of heart attack
COPERNICAN PICCOLETO VIII is a prospective, pragmatic, multicenter, non-inferiority, randomised clinical trial that compares the effectiveness of a reduced stent strategy using drug-coated balloons …
The largest congress in Europe dedicated to Drug-Eluting Balloon (DEB) angioplasty will take place in Rome on January 30-31, in collaboration with the DCB Academy. This event will focus on the latest advancements in drug-coated balloons for coronary interventions. Leading global experts will gather to present live case demonstrations, interactive sessions, and in-depth discussions. This congress offers a unique opportunity for students and physicians interested in interventional cardiology to enhance their scientific knowledge and practical skills. For more details and to register, please visit: www.debstoriescongress.com
SIGN UP NOW